Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a sponsor to co-GP on projects in high-demand areas like San Francisco and Boston.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor/operator at the GP level to capitalize on the influx of venture capital and NIH funding.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in securing leases and managing properties in high-demand areas like San Francisco.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a seasoned operator to co-GP on lab space developments, leveraging their expertise to share in the promote.

Co-GP / Platform:A family office could deploy into the Houston life sciences market by backing a sponsor/operator focused on developing biopharmaceutical facilities, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of high-quality lab assets.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on those with a strong pipeline and operational efficiency.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor focused on properties near research universities and hospitals, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor focused on biomanufacturing or biotech incubators to share in the promote and benefit from a growing pipeline of tenants.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of leasing opportunities.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor or operator at the GP level to share in the promote and access new developments near key research institutions.

Co-GP / Platform:A family office could deploy into the San Francisco life science market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a robust pipeline of new developments.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor or operator at the GP level, capitalizing on the growing demand for life science facilities adjacent to healthcare ecosystems.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a local operator or sponsor at the GP level, sharing in the promote and benefiting from a repeatable pipeline of lab space developments.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from the sector's growth.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator involved in the development of new properties like TMC Helix Park, ensuring alignment and access to a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in developing specialized facilities, sharing in the promote and benefiting from a strong pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a strong operational history, focusing on established markets like Boston or San Francisco to share in the promote and access a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests for future growth.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator at the GP level, capitalizing on the significant funding and development of lab spaces.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of new developments.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from the strong funding landscape.